Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Jul 21, 2022

SELL
$3.2 - $5.69 $160,000 - $284,500
-50,000 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$2.8 - $7.39 $32,199 - $84,985
-11,500 Reduced 18.7%
50,000 $224,000
Q4 2021

Jan 25, 2022

BUY
$5.92 - $9.98 $364,080 - $613,770
61,500 New
61,500 $272,000

Others Institutions Holding EQRX

About EQRx, Inc.


  • Ticker EQRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 448,140,992
  • Description
  • EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...
More about EQRX
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.